Cellcolabs AB is a Swedish AB based in Solna, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2021, the company has 68 employees and reported revenue of SEK 44.2m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Payas, Nathan Firman tecknas var för sig av Hendéus Levén, Emma Katarina Plöen, Erik Patrik Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, direkt eller indirekt genom hel- eller delägda bolag, producera och sälja cellprodukter för användning i samband med behandling av olika sjukdomstillstånd. Bolaget kommer även att bedriva forskning och processutveckling inom cellproduktion. Bolaget får dessutom handla med noterade och onoterade värdepapper.
In its most recent annual report (2025), Cellcolabs AB reported revenue of SEK 44.2m, an increase of 189% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 97.6m, and the EBITDA margin stood at -214%.
At the end of 2025, equity financed 87.8% of the balance sheet, and current assets covered short-term debt 7.6 times.
Frequently asked questions
What is the Org number of Cellcolabs AB?
Cellcolabs AB is registered with Bolagsverket / SCB under Org 5593126955.
What is the revenue of Cellcolabs AB?
Cellcolabs AB reported revenue of SEK 44.2m in 2025.
How many employees does Cellcolabs AB have?
Cellcolabs AB employs 68 people as of the latest annual report.
Who is the CEO of Cellcolabs AB?
Vincent Metzler is the CEO of Cellcolabs AB, in role since 2026.
Who is the chairman of Cellcolabs AB?
Eva Maria Halling Rankka chairs the board of Cellcolabs AB.
Where is Cellcolabs AB headquartered?
Cellcolabs AB's registered address is Scheeles Väg 5.
